N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one

C86H110N13O13S2+ — CID 159520518

IUPACN-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one
SMILESCCN(Cc1cnn2cccnc12)c1cccc(OCCOc2ccc(C)cc2)c1.CCOc1cc(CNCCN2CCOCC2)ccc1OCc1cccs1.COc1ccc(OC[C@H](O)C[NH+](C)Cc2c(-c3ccco3)[nH]c3ncccc23)cc1.O=C(CCCS(=O)(=O)N1CCCC1)c1cccnc1N1CCN(CCO)CC1
InChIInChI=1S/C24H26N4O2.C23H25N3O4.C20H28N2O3S.C19H30N4O4S/c1-3-27(18-20-17-26-28-13-5-12-25-24(20)28)21-6-4-7-23(16-21)30-15-14-29-22-10-8-19(2)9-11-22;1-26(13-16(27)15-30-18-9-7-17(28-2)8-10-18)14-20-19-5-3-11-24-23(19)25-22(20)21-6-4-12-29-21;1-2-24-20-14-17(15-21-7-8-22-9-11-23-12-10-22)5-6-19(20)25-16-18-4-3-13-26-18;24-15-14-21-10-12-22(13-11-21)19-17(5-3-7-20-19)18(25)6-4-16-28(26,27)23-8-1-2-9-23/h4-13,16-17H,3,14-15,18H2,1-2H3;3-12,16,27H,13-15H2,1-2H3,(H,24,25);3-6,13-14,21H,2,7-12,15-16H2,1H3;3,5,7,24H,1-2,4,6,8-16H2/p+1/t;16-;;/m.1../s1
InChIKeyMBSWYPITKGEFJE-WMVBMBIMSA-O
MW1598.04 g/mol
LogP10.54
Rot. Bonds37

About N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one

N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one (PubChem CID 159520518) has the molecular formula C86H110N13O13S2+ and a molecular weight of 1598.04 g/mol. Its IUPAC name is N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one.

Molecular Properties

Compound NameN-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one
PubChem CID159520518
Molecular FormulaC86H110N13O13S2+
Molecular Weight1598.04 g/mol
Exact Mass1596.78
IUPAC NameN-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one
SMILESCCN(Cc1cnn2cccnc12)c1cccc(OCCOc2ccc(C)cc2)c1.CCOc1cc(CNCCN2CCOCC2)ccc1OCc1cccs1.COc1ccc(OC[C@H](O)C[NH+](C)Cc2c(-c3ccco3)[nH]c3ncccc23)cc1.O=C(CCCS(=O)(=O)N1CCCC1)c1cccnc1N1CCN(CCO)CC1
InChIInChI=1S/C24H26N4O2.C23H25N3O4.C20H28N2O3S.C19H30N4O4S/c1-3-27(18-20-17-26-28-13-5-12-25-24(20)28)21-6-4-7-23(16-21)30-15-14-29-22-10-8-19(2)9-11-22;1-26(13-16(27)15-30-18-9-7-17(28-2)8-10-18)14-20-19-5-3-11-24-23(19)25-22(20)21-6-4-12-29-21;1-2-24-20-14-17(15-21-7-8-22-9-11-23-12-10-22)5-6-19(20)25-16-18-4-3-13-26-18;24-15-14-21-10-12-22(13-11-21)19-17(5-3-7-20-19)18(25)6-4-16-28(26,27)23-8-1-2-9-23/h4-13,16-17H,3,14-15,18H2,1-2H3;3-12,16,27H,13-15H2,1-2H3,(H,24,25);3-6,13-14,21H,2,7-12,15-16H2,1H3;3,5,7,24H,1-2,4,6,8-16H2/p+1/t;16-;;/m.1../s1
InChIKeyMBSWYPITKGEFJE-WMVBMBIMSA-O
XLogP10.54
TPSA273.85 Ų
H-Bond Donors5
H-Bond Acceptors24
Rotatable Bonds37
Heavy Atoms114
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001598.04
LogP ≤ 510.54
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one?
The IUPAC name of N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one (CID 159520518) is N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one.
What is the SMILES notation for N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one?
The canonical SMILES for N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one is CCN(Cc1cnn2cccnc12)c1cccc(OCCOc2ccc(C)cc2)c1.CCOc1cc(CNCCN2CCOCC2)ccc1OCc1cccs1.COc1ccc(OC[C@H](O)C[NH+](C)Cc2c(-c3ccco3)[nH]c3ncccc23)cc1.O=C(CCCS(=O)(=O)N1CCCC1)c1cccnc1N1CCN(CCO)CC1.
What is the InChIKey of N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one?
The InChIKey is MBSWYPITKGEFJE-WMVBMBIMSA-O. The full InChI is InChI=1S/C24H26N4O2.C23H25N3O4.C20H28N2O3S.C19H30N4O4S/c1-3-27(18-20-17-26-28-13-5-12-25-24(20)28)21-6-4-7-23(16-21)30-15-14-29-22-10-8-19(2)9-11-22;1-26(13-16(27)15-30-18-9-7-17(28-2)8-10-18)14-20-19-5-3-11-24-23(19)25-22(20)21-6-4-12-29-21;1-2-24-20-14-17(15-21-7-8-22-9-11-23-12-10-22)5-6-19(20)25-16-18-4-3-13-26-18;24-15-14-21-10-12-22(13-11-21)19-17(5-3-7-20-19)18(25)6-4-16-28(26,27)23-8-1-2-9-23/h4-13,16-17H,3,14-15,18H2,1-2H3;3-12,16,27H,13-15H2,1-2H3,(H,24,25);3-6,13-14,21H,2,7-12,15-16H2,1H3;3,5,7,24H,1-2,4,6,8-16H2/p+1/t;16-;;/m.1../s1.
What are the key properties of N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one?
N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one has a molecular weight of 1598.04 g/mol, XLogP of 10.54, 37 rotatable bonds, 5 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[3-ethoxy-4-(thiophen-2-ylmethoxy)phenyl]methyl]-2-morpholin-4-ylethanamine;N-ethyl-3-[2-(4-methylphenoxy)ethoxy]-N-(pyrazolo[1,5-a]pyrimidin-3-ylmethyl)aniline;[2-(furan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]methyl-[(2R)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-methylazanium;1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-3-pyridinyl]-4-pyrrolidin-1-ylsulfonylbutan-1-one is sourced from PubChem (CID 159520518), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).